Although this difference did not reach statistical significance in this cohort (log-rank p = 0.14), these data suggest that elevated CHPT1 levels may be linked to poorer clinical outcomes and support the potential relevance of CHPT1 as a candidate biomarker and therapeutic vulnerability in CRC. 3.5.
← all excerpts
Phosphatidylcholine and CHPT1 as Central Drivers of Chemoresistance in Colorectal Cancer: Lipidomic and Functional Insights.
2
0.1400
0.1400
The sentences
Kaplan–Meier analysis showed a trend toward reduced overall survival in patients with high CHPT1 expression compared with those with low expression ( Figure 6 B).